Characterization of Malignant Focal Liver Lesions with Contrast-Enhanced 40 MHz Ultrasound Imaging in Hepatitis B Virus X Transgenic Mice: A Feasibility Study

Abstract

Contrast-enhanced ultrasound (CEUS) imaging has been a reliable clinical method of detecting three vascular contrast phases and characterizing focal liver lesions. Previous results were all from human (i.e., clinical studies). The main purpose of this study was to extend this to small animals and to investigate the feasibility of using CEUS in preclinical research. Specifically, high-frequency (40 MHz) ultrasound liver imaging with albumin-shelled microbubbles was employed to detect the three vascular contrast phases and characterize focal liver lesions that developed in thirteen Hepatitis B virus X (HBx) transgenic mice at around 14 to 16 months of age. Previous studies indicated that 90–100% incidence of hepatocellular carcinoma (HCC) was observed in HBx transgenic male mice. After injecting the contrast agent, the time-intensity curves (TICs) of focal liver lesions, vessels in focal liver lesions and surrounding liver parenchyma tissues were measured for 30 minutes. The peak of mean intensity relative to the baseline increased 7.36 dB (p<0.02). On the other hand, the mean contrast between the focal liver lesion and the liver parenchyma increased by 7.74 (p<0.05) dB, thus allowing clear detection of the lesion margin. Histopathology investigations confirmed the development of the lesion in these mice. In addition, guidelines of European Federation of Societies for Ultrasound in Medicine and Biology were followed as an attempt to characterize features of the TICs in mice. The arterial phase was defined as 2 to 60 seconds post contrast injection, and the parenchyma phase was defined as the time period from 10 to 30 minutes post contrast injection. Comparing the imaging with the pathology results, the sensitivity, specificity and accuracy of CEUS for the detection of malignant focal liver lesion in HBx transgenic mice were 91%, 100% and 92%. These results demonstrated that high-frequency CEUS imaging potentially can be used for detecting the three vascular contrast phases of malignant focal liver lesions and characterizing malignant focal liver lesions in mice. Thus can be a valuable tool in preclinical research.

Keywords

High-frequency ultrasound malignant focal liver lesion microbubble time-intensity curves

Get full access to this article

View all access options for this article.

References

Bolondi

Correas

Lencioni

Weskott

Piscaglia

New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice, Dig Liver Dis 39, 187–195 (2007).

Solbiati

Martegani

Leen

Contrast-Enhanced Ultrasound of Liver Diseases (Springer, Milan: Italy, 2003).

Matsui

Kadoya

Kameyama

Benign and malignant nodules in cirrhotic livers: distinction based on blood supply, Radiology 178, 493–497 (1991).

Efremidis

Hytiroglou

The multistep process of hepatocarcinogenesis in cirrhosis with imaging correlation, Eur Radiol 12, 753–764 (2002).

Kojiro

Nakashima

Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors, Semin Liver Dis 19, 287–296 (1999).

Giorgio

Ferraioli

Tarantino

Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance, Am J Roentgenol 183, 1319–1326 (2004).

Jang

Kim

Wilson

. Imaging of malignant liver masses: characterization and detection, Ultrasound Q 22, 19–29 (2006).

Leen

The role of contrast-enhanced ultrasound in the characterization of focal liver lesions, Eur Radiol 11, E27–E34 (2001).

Tanaka

Ioka

Oshikawa

Hamada

Yoshioka

Dynamic sonography of hepatic tumors, Am J Roentgenol 177, 799–805 (2001).

10.

Wilson

Burns

Muradali

Wilson

Lai

Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis, Radiology 215, 147–151 (2000).

11.

Foster

Pavlin

Harasiewicz

Christopher

Turnbull

. Advances in ultrasound biomicroscopy, Ultrasound Med Biol 26, 1–27 (2000).

12.

Knapik

Starkoski

Pavlin

Foster

. A 100–200 MHz ultrasound biomicroscope, IEEE Trans Ultrason Ferroelectr Freq Contr 47, 1540–1549 (2000).

13.

Goertz

Kerbel

Burns

Foster

. High-frequency 3-D color-flow imaging of the microcirculation, Ultrasound Med Biol 29, 39–51 (2003).

14.

Graham

Wirtzfeld

MacKenzie

Three-dimensional high-frequency ultrasound imaging for longitudinal evaluation of liver metastases in preclinical models, Cancer Res 65, 5231–5237 (2005).

15.

Wirtzfeld

Graham

Groom

Volume measurement variability in three-dimensional high-frequency ultrasound images of murine liver metastases, Phys Med Biol 51, 2367–2381 (2006).

16.

Chen

Guan

. A digital ultrasonic system for small animal imaging, Ultrasonic Imaging 26, 85–99 (2004).

17.

Yanagisawa

Moriyasu

Miyahara

Yuki

Iijima

Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells, Ultrasound Med Biol 33, 318–325 (2007).

18.

Huang-Wei

Bleuzen

Bourlier

Differential diagnosis of focal nodular hyperplasia with quantitative parametric analysis in contrast-enhanced sonography, Invest Radiol 41, 363–368 (2006).

19.

Albrecht

Blomley

Bolondi

Guidelines for the use of contrast agents in ultrasound. January 2004, Ultraschall Med 25, 249–256 (2004).

20.

Chen

Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice, Biochem Biophys Res Commun 340, 916–928 (2006).

21.

Dittrich

Bales

Kuvelas

Myocardial contrast echocardiography in experimental coronary artery occlusion with a new intravenously administered contrast agent, J Am Soc Echocardiogr 8, 465–474 (1995).

22.

Cohen

Cheirif

Segar

Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial, J Am Coll Cardiol 32, 746–752 (1998).

23.

Nicolau

Vilana

Catalá

Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions, Am J Roentgenol 186, 158–167 (2006).

24.

Goertz

Cherin

Needles

High Frequency Nonlinear B-Scan Imaging of Microbubble Contrast Agents, IEEE Trans Ultrason Ferroelectr Freq Contr 52, 65–79 (2005).

25.

Goertz

Needles

Burns

High-frequency, nonlinear flow imaging of microbubble contrast agents, IEEE Trans Ultrason Ferroelectr Freq Contr 52, 495–503 (2005).

26.

Kojiro

Pathology of Hepatocellular Carcinoma (Blackwell Pub, Malden, MA, 2006).

27.

Quinlan

Martin

Evans

. Albumin: biochemical properties and therapeutic potential, Hepatology 41, 1211–1219 (2005).

28.

Mai

Barraud

Lefrancois

Ultrasound detection of spontaneous hepato-cellular carcinomas in X/myc bitransgenic mice, Liver Int 24, 651–657 (2004).

29.

Couture

Bevan

Cherin

Investigating perfluorohexane particles with high-frequency ultrasound, Ultrasound Med Biol 32, 73–82 (2006).